Literature DB >> 26694981

Surgical management of oropharyngeal squamous cell carcinoma: Survival and functional outcomes.

Bhavna Kumar1, Michael J Cipolla1, Matthew O Old1, Nicole V Brown1, Stephen Y Kang1, Peter T Dziegielewski1, Kasim Durmus1, Enver Ozer1, Amit Agrawal1, Ricardo L Carrau1, David E Schuller1, Marino E Leon1, Quintin Pan1, Pawan Kumar1, Valerie Wood1, Jessica Burgers1, Paul E Wakely1, Theodoros N Teknos1.   

Abstract

BACKGROUND: The purpose of this study was to further define the impact of primary surgery in the management of oropharyngeal squamous cell carcinoma (SCC).
METHODS: Two hundred ninety-six patients with oropharyngeal SCC treated with primary surgery were included. Multivariable analysis and recursive partitioning analysis (RPA) identified predictors of survival and gastrostomy tube presence.
RESULTS: Multivariable analysis identified that HPV negativity (p = .0002), presence of extranodal extension (p = .0025), and advanced T classification (p = .0081) were independent predictors of survival. For HPV-positive patients, surgical approach (p = .0111) and margin status (p = .0287) were significant predictors of survival. For HPV-negative patients, extranodal extension (p = .0021) and advanced T classification (p = .0342) were significant predictors of survival. Smoking status and advanced neck disease did not impact survival, and the addition of adjuvant chemotherapy did not confer survival benefit in HPV-positive or HPV-negative subgroups.
CONCLUSION: Independent predictors of survival are unique in patients with oropharyngeal SCC treated with primary surgery.
© 2015 Wiley Periodicals, Inc. Head Neck 38: E1794-E1802, 2016. © 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  human papillomavirus; oropharyngeal cancer; squamous cell carcinoma; surgery oropharynx; transoral surgery

Mesh:

Year:  2015        PMID: 26694981     DOI: 10.1002/hed.24319

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  13 in total

1.  Biological Features of Human Papillomavirus-related Head and Neck Cancers Contributing to Improved Response.

Authors:  C Cleary; J E Leeman; D S Higginson; N Katabi; E Sherman; L Morris; S McBride; N Lee; N Riaz
Journal:  Clin Oncol (R Coll Radiol)       Date:  2016-04-01       Impact factor: 4.126

2.  Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.

Authors:  Huaising C Ko; Paul M Harari; Ryan M Sacotte; Shuai Chen; Aaron M Wieland; Menggang Yu; Andrew M Baschnagel; Justine Y Bruce; Randall J Kimple; Matthew E Witek
Journal:  J Cancer Res Clin Oncol       Date:  2017-07-27       Impact factor: 4.553

3.  Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.

Authors:  Mehdi Taghipour; Esther Mena; Matthew J Kruse; Sara Sheikhbahaei; Rathan M Subramaniam
Journal:  Nucl Med Commun       Date:  2017-03       Impact factor: 1.690

4.  The Role of Adjuvant Chemotherapy in Surgically Managed, p16-Positive Oropharyngeal Squamous Cell Carcinoma.

Authors:  S Andrew Skillington; Dorina Kallogjeri; James S Lewis; Jay F Piccirillo
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-03-01       Impact factor: 6.223

5.  Impact of HPV Status on the Prognostic Potential of the AJCC Staging System for Larynx Cancer.

Authors:  Stacey M Davidson; Huasing C Ko; Paul M Harari; Aaron M Wieland; Shuai Chen; Andrew M Baschnagel; Randall J Kimple; Matthew E Witek
Journal:  Otolaryngol Head Neck Surg       Date:  2018-04-03       Impact factor: 3.497

6.  Predictors of gastrostomy tube dependence in surgically managed oropharyngeal squamous cell carcinoma.

Authors:  Vivek R Varma; Antoine Eskander; Stephen Y Kang; Bhavna Kumar; Nicole V Brown; Songzhu Zhao; Guy Brock; Amit Agrawal; Ricardo L Carrau; Matthew O Old; Enver Ozer; James W Rocco; David E Schuller; Peter T Dziegielewski; Michael J Cipolla; Theodoros N Teknos
Journal:  Laryngoscope       Date:  2018-09-08       Impact factor: 3.325

7.  Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx.

Authors:  B H Haughey; P Sinha; D Kallogjeri; R L Goldberg; J S Lewis; J F Piccirillo; R S Jackson; E J Moore; M Brandwein-Gensler; S J Magnuson; W R Carroll; T M Jones; M D Wilkie; A Lau; N S Upile; Jon Sheard; J Lancaster; S Tandon; M Robinson; D Husband; I Ganly; J P Shah; D M Brizel; B O'Sullivan; J A Ridge; W M Lydiatt
Journal:  Oral Oncol       Date:  2016-09-23       Impact factor: 5.337

8.  Transoral Resection of Human Papillomavirus (HPV)-Positive Squamous Cell Carcinoma of the Oropharynx: Outcomes with and Without Adjuvant Therapy.

Authors:  Ryan S Jackson; Parul Sinha; Joseph Zenga; Dorina Kallogjeri; Jasmina Suko; Eliot Martin; Eric J Moore; Bruce H Haughey
Journal:  Ann Surg Oncol       Date:  2017-08-14       Impact factor: 5.344

9.  20 pack-year smoking history as strongest smoking metric predictive of HPV-positive oropharyngeal cancer outcomes.

Authors:  Stephanie Y Chen; Aisling Last; Abhinav Ettyreddy; Dorina Kallogjeri; Benjamin Wahle; Smrithi Chidambaram; Angela Mazul; Wade Thorstad; Ryan S Jackson; Jose P Zevallos; Patrik Pipkorn
Journal:  Am J Otolaryngol       Date:  2021-01-13       Impact factor: 1.808

10.  Transoral robotic surgery with radial forearm free flap reconstruction: case control analysis.

Authors:  Vincent L Biron; Daniel A O'Connell; Brittany Barber; Jessica M Clark; Colin Andrews; Caroline C Jeffery; David W J Côté; Jeffrey Harris; Hadi Seikaly
Journal:  J Otolaryngol Head Neck Surg       Date:  2017-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.